RRML - Serum tumor markers for screening and early diagnosis of ovarian cancer
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2020): 75%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- May 2021 -
 
Prognostic value of serum lact... 15
Romanian Review of Laboratory ... 8
Pseudohyponatremia and falsely... 8
Vaginal candidiasis in Konya a... 7
The possibility of clinical us... 7
Evaluation of Plasma AA/DHA+EP... 6
Prevalence of ∆F508 cystic f... 6
Predictors associated with inc... 6
Reliability of Friedewald form... 5
Frequency, Distribution and Ge... 5

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 21(4)/2013 DOI:10.2478/rrlm-2013-0046
XML
TXT

Serum tumor markers for screening and early diagnosis of ovarian cancer

Octavian Gabriel J. Olaru, Cătălina Monica C. Pena


Abstract:

Discovery of new biomarkers or panels of biomarkers for early diagnosis of ovarian cancer is one of the great challenges of modern medicine. The use of determination of CA125 (the most commonly used biomarker) was improved by taking into account the dynamic values available in the context of screening. Currently, the highest sensitivity of screening tests performed for early diagnosis of ovarian cancer is 96% and was obtained using a panel of serum biomarkers composed of apolipoprotein A1, transthyretin, transferrin and CA125. This paper presents different types of serum proteins that are currently studied, and should be proposed as new biomarkers for detecting ovarian cancer. Future research needs to be conducted in order to find a new tumor marker panel that is quantitative, reproducible, and fast and has an even higher sensitivity and specificity for the early detection of ovarian cancer.

Keywords: ovarian cancer,early diagnosis,serum biomarkers or serum tumor markers,sensitivity,specificity

 
  PDF Download full text PDF
(128 KB)
     
 
How to cite
Olaru OGJ, Pena CMC. Serum tumor markers for screening and early diagnosis of ovarian cancer. Rev Romana Med Lab. 2013;21(4):465-72. DOI:10.2478/rrlm-2013-0046